FinanceCity
HealthcareNSE · BSE

Gland Pharma Limited

GLAND · ISIN INE068V01023

Share price

₹2,202 -0.49%

Market capitalisation

₹36327 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹36327 Cr

Current price

₹2,202

-0.49% today

52W high

₹2,396

52W low

₹1,574

Stock P/E

35.41

P/B ratio

3.5

02 · Per share & returns

EPS (TTM)

₹62.19

Book value

₹629

ROE

10.53%

ROA

6.35%

Dividend yield

0.90%

Beta

0.5

03 · Financials (TTM)

By the numbers

Revenue

₹6431 Cr

+22.30% YoY

EBITDA

₹1630 Cr

Net profit

₹1027 Cr

+96.40% YoY

Profit margin

15.97%

Operating margin

23.20%

Total debt

₹284 Cr

Total cash

₹3433 Cr

Debt / equity

0.03x

Current ratio

4.68x

Payout ratio

28.90%

04 · Analyst view

Target price

₹2,190

Upside

-0.57%

Consensus

BUY

Analysts

14

05 · Shareholding pattern

Who owns GLAND?

  • Promoters

    51.83%

    Founders & promoter group

  • Institutions

    36.25%

    FII + DII

  • Public

    11.92%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
GLAND
Exchange
NSE · BSE
CIN
ISIN
INE068V01023
BSE code
543245
Sector
Healthcare
Industry
Healthcare
Face value
₹1
Listing date
19 Nov 2020
Employees
Headquarters
Hyderabad, India

07 · About

What is Gland Pharma Limited?

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

08 · Common questions

Frequently asked

What is the CIN of Gland Pharma Limited?+

The Corporate Identity Number for Gland Pharma Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Gland Pharma Limited?+

Promoter holding in GLAND is approximately 51.83%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Gland Pharma Limited?+

Gland Pharma Limited (GLAND) has a market capitalisation of approximately ₹36327 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →